OPK-88006

N/A

Report date: 2026/04/08 20:02:35
NME

Base Information

Drug NameOPK-88006
Drug Alias NameOXMLong-acting oxyntomodulin analog(Opko Health)OPK-88006
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGlucagon receptor agonistsGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 2 receptorGlucagon-like peptide 1 receptorGlucagon receptor
Therapy Area/IndicationsObesityMetabolic DiseasesMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesEntera Bio LtdOpko Health Inc
China Registration ClassN/A

Develop Information

Active CompaniesOpko Health IncEntera Bio Ltd
Inactive CompaniesN/A
Active IndicationsObesityMetabolic DiseasesMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A